Complete Genomics Aims for Positive Cash Flow by Mid-2010; Position Itself for IPO | GenomeWeb

By Julia Karow

This article was originally published Dec. 2.

Complete Genomics expects to become cash-flow positive by mid 2010, following rapid revenue growth, and plans to position itself in 2010 for an initial public offering, according to the company's chief executive.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.